TSX:EXE

Extendicare Inc. · TSX · Healthcare · CAD · FY for 2025

Figures on this page computed 2026-11-08 13:02 UTC

Last close

n/aCAD

Market data

24.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed
- Computed from the filing for 2025
28.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
5.8%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
3.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.92Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
1.7%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed

Safety is the furthest below its sector's middle: 0.50 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

157

2016-12-31 to 2025-12-31100 at the start157

Sales: 100.00 on 2016-12-31 to 156.53 on 2025-12-31, up 57%.

Profit

273

2016-12-31 to 2025-12-31100 at the start273

Profit: 100.00 on 2016-12-31 to 272.64 on 2025-12-31, up 173%.

Shares in issue

87.2

2016-12-31 to 2025-12-31100 at the start87.2

Shares in issue: 100.00 on 2016-12-31 to 87.17 on 2025-12-31, down 13%.

Sales is at 156, Profit is at 273, Shares in issue is at 87, against 100 in 2016.

Sales is at 156, Profit is at 273, Shares in issue is at 87, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100157
Source
computed
Statement
income
Fiscal year
2025
Reported in
CAD
Profit, where the first year is 100273
Source
computed
Statement
income
Fiscal year
2025
Reported in
CAD
Shares in issue, where the first year is 10087
Source
computed
Statement
income
Fiscal year
2025
Reported in
CAD